TY - JOUR T1 - Antiproliferative effect of silver compounds containing benzimidazole ring AU - Bahar, Dilek AU - Akkoç, Senem AU - Özkan, Buket Banu PY - 2025 DA - April Y2 - 2024 DO - 10.23902/trkjnat.1549105 JF - Trakya University Journal of Natural Sciences JO - Trakya Univ J Nat Sci PB - Trakya University WT - DergiPark SN - 2528-9691 SP - 1 EP - 8 VL - 26 IS - 1 LA - en AB - With its significant biological activities, the benzimidazole nucleus is a crucial pharmacophore in medicine. Recent studies have focused on the synthesis and biological activity of benzimidazole compounds. Therefore, this study prepared a series of N-heterocyclic silver compounds containing benzimidazole nuclei. These complexes were cultured with lung (A549), colon (CaCo2), breast (MCF7), prostate (PC3) cancer cell lines, and healthy lung (WI38) cell line, and their anticancer effects were investigated through MTT, apoptosis determination, and oxidative stress tests. The results revealed that the presence of drug candidates was more practical than that of commercially used cisplatin. KW - Apoptosis KW - cytotoxic activity KW - Ag-NHC KW - oxidative stress. N2 - Benzimidazol çekirdeği önemli biyolojik aktiviteleri ile tıpta önemli bir farmakofordur. Son çalışmalar benzimidazol bileşiklerinin sentezi ve biyolojik aktivitesine odaklanmıştır. Bu nedenle, bu çalışmada benzimidazol çekirdekleri içeren bir dizi N-heterosiklik gümüş bileşiği hazırlamıştır. Bileşiklerin etkilerini incelemek için in vitro hücre kültür deneyleri yapılmıştır. Bileşikler akciğer (A549), kolon (CaCo2), meme (MCF7), prostat (PC3) kanser hücre hatları ve sağlıklı akciğer (WI38) hücre hattı ile kültüre edilmiş ve bileşiklerin antikanser etkileri bu hücreler üzerinde MTT hücre çoğalma testi, apoptoz tayini ve oksidatif stres testleri yapılarak araştırılmıştır. Sonuçlar ilaç adaylarının varlığının ticari olarak kullanılan sisplatinden daha pratik olduğunu ortaya koymuştur. CR - 1. Abdelgawad, M.A., Bakr, R.B., Ahmad, W., Al-Sanea, M.M. & Elshemy, H.A.H. 2019. New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition. Bioorganic Chemistry, 92: 1-6. https://doi.org/10.1016/j.bioorg.2019.103218 CR - 2. Akkoç, S. 2019. Derivatives of 1‐(2‐(Piperidin‐1‐yl) ethyl)‐1H‐benzo [d] imidazole: Synthesis, characterization, determining of electronic properties and cytotoxicity studies. ChemistrySelect, 4(17): 4938-4943. https://doi.org/10.1002/slct.201900353 CR - 3. Akkoç, S., Gök, Y., İlhan, İ.Ö. & Kayser, V. 2016a. N-Methylphthalimide-substituted benzimidazolium salts and PEPPSI Pd–NHC complexes: synthesis, characterization and catalytic activity in carbon–carbon bond-forming reactions. Beilstein Journal of Organic Chemistry, 12(1): 81-88. https://doi.org/10.3762/bjoc.12.9 CR - 4. Akkoç, S., Gök, Y., Özdemir, İ. & Günal, S. 2014. N-Heterocyclic Carbene Silver Complexes: Synthesis, Characterization and in Vitro Antimicrobial Studies. Journal of the Chinese Advanced Materials Society, 2(1): 20-30. https://doi.org/10.1080/22243682.2014.882795 CR - 5. Akkoç, S., Kayser, V. & İlhan, İ.Ö. 2019. Synthesis and in vitro anticancer evaluation of some benzimidazolium salts. Journal of Heterocyclic Chemistry, 56(10): 2934-2944. https://doi.org/10.1002/jhet.3687 CR - 6. Akkoç, S., Kayser, V., İlhan, İ.Ö., Hibbs, D.E., Gök, Y., Williams, P.A., Hawkins, B. & Lai, F. 2017. New compounds based on a benzimidazole nucleus: synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines. Journal of Organometallic Chemistry, 839: 98-107. https://doi.org/10.1016/j.jorganchem.2017.03.037 CR - 7. Akkoç, S., Özer İlhan, İ., Gök, Y., Upadhyay, P.J. & Kayser, V. 2016b. In vitro cytotoxic activities of new silver and PEPPSI palladium N-heterocyclic carbene complexes derived from benzimidazolium salts. Inorganica Chimica Acta, 449: 75-81. https://doi.org/10.1016/j.ica.2016.05.001 CR - 8. Aslan, H. G., Akkoç, S. & Kökbudak, Z. 2020. Anticancer activities of various new metal complexes prepared from a Schiff base on A549 cell line. Inorganic Chemistry Communications, 111: 11-6. https://doi.org/10.1016/j.inoche.2019.107645 CR - 9. Bansal, Y. & Silakari, O. 2012. The therapeutic journey of benzimidazoles: A review. Bioorganic Medicinal Chemistry, 20(21): 6208-6236. https://doi.org/10.1016/j.bmc.2012.09.013 CR - 10. Block, K.I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A.R., Amin, A., Ashraf, S.S. 2015. A broad-spectrum integrative design for cancer prevention and therapy. In Seminars in Cancer Biology, 35(Suppl): 276-304. https://doi:10.1016/j.semcancer.2015.09.007 CR - 11. Chaicharoenaudomrung, N., Kunhorm, P. & Noisa, P. 2019. Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling. World Journal of Stem Cells, 11(12): 1065-1083. https://doi:10.4252/wjsc.v11.i12.1065 CR - 12. Gök, Y., Akkoç, S., Albayrak, S., Akkurt, M. & Tahir, M.N. 2014. N‐Phenyl‐substituted carbene precursors and their silver complexes: synthesis, characterization and antimicrobial activities. Applied Organometallic Chemistry, 28(4): 244-251. https://doi.org/10.1002/aoc.3116 CR - 13. Gök, Y., Akkoc, S., Çelikal, Ö.Ö., Özdemir, İ. & Günal, S. 2019. In vitro antimicrobial studies of naphthalen-1-ylmethyl substituted silver N-heterocyclic carbene complexes. Arabian Journal of Chemistry, 12(8): 2513-2518. https://doi.org/10.1016/j.arabjc.2015.04.019 CR - 14. Siegel, R., Giaquinto A.N. & Jemal A. 2024. Cancer statistics. CA: A Cancer Journal For Clinicians, 60(5): 277-300. https://doi.org/10.3322/caac.21820 CR - 15. Liu, T., Sun, C., Xing, X., Jing, L., Tan, R., Luo, Y. & Zhao, Y. 2012. Synthesis and evaluation of 2-[2-(phenylthiomethyl)-1H-benzo [d] imidazol-1-yl) acetohydrazide derivatives as antitumor agents. Bioorganic & Medicinal Chemistry Letters, 22(9): 3122-3125. https://doi.org/10.1016/j.bmcl.2012.03.061 CR - 16. Mavrova, A.T., Wesselinova, D., Vassilev, N. & Tsenov, J.A. 2013. Design, synthesis and antiproliferative properties of some new 5-substituted-2-iminobenzimidazole derivatives. European Journal of Medicinal Chemistry, 63: 696-701. https://doi.org/10.1016/j.ejmech.2013.03.010 CR - 17. Özil, M., Parlak, C. & Baltaş, N. 2018. A simple and efficient synthesis of benzimidazoles containing piperazine or morpholine skeleton at C-6 position as glucosidase inhibitors with antioxidant activity. Bioorganic Chemistry, 76: 468-477. https://doi.org/10.1016/j.bioorg.2017.12.019 CR - 18. Shingalapur, R.V., Hosamani, K.M., Keri, R.S. & Hugar, M.H. 2010. Derivatives of benzimidazole pharmacophore: Synthesis, anticonvulsant, antidiabetic and DNA cleavage studies. European Journal of Medicinal Chemistry, 45(5): 1753-1759. https://doi.org/10.1016/j.ejmech.2010.01.007 CR - 19. Taha, M., Mosaddik, A., Rahim, F., Ali, S., Ibrahim, M. & Almandil, N.B., 2018. Synthesis, antiglycation and antioxidant potentials of benzimidazole derivatives. Journal of King Saud University -Science, 32(1): 191-194. https://doi.org/10.1016/j.jksus.2018.04.003 CR - 20. Thimmegowda, N.R., Swamy, S.N., Kumar, C.A., Kumar, Y.S., Chandrappa, S., Yip, G. W. & Rangappa, K.S. 2008. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Bioorganic & Medicinal Chemistry Letters. 18(1): 432-435. https://doi.org/10.1016/j.bmcl.2007.08.078 CR - 21. Tonelli, M., Novelli, F., Tasso, B., Vazzana, I., Sparatore, A., Boido, V., Sparatore, F., La Colla, P., Sanna, G., Giliberti, G., Busonera, B., Farci, P., Ibba, C. & Loddo, R. 2014. Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents. Bioorganic Medicinal Chemistry, 22(17): 4893-4909. https://doi.org/10.1016/j.bmc.2014.06.043 UR - https://doi.org/10.23902/trkjnat.1549105 L1 - https://dergipark.org.tr/en/download/article-file/4210109 ER -